These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 22211893)

  • 1. Diabetes, cancer, and metformin: connections of metabolism and cell proliferation.
    Gallagher EJ; LeRoith D
    Ann N Y Acad Sci; 2011 Dec; 1243():54-68. PubMed ID: 22211893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes mellitus and the risk of cancer.
    Pandey A; Forte V; Abdallah M; Alickaj A; Mahmud S; Asad S; McFarlane SI
    Minerva Endocrinol; 2011 Sep; 36(3):187-209. PubMed ID: 22019750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diabetes and cancer risk: oncologic considerations].
    Rosta A
    Orv Hetil; 2011 Jul; 152(29):1144-55. PubMed ID: 21712179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin and cancer: licence to heal?
    Papanas N; Maltezos E; Mikhailidis DP
    Expert Opin Investig Drugs; 2010 Aug; 19(8):913-7. PubMed ID: 20557275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlations of insulin resistance and neoplasms].
    Suba Z; Ujpál M
    Magy Onkol; 2006; 50(2):127-35. PubMed ID: 16888676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes and cancer: a consensus report.
    Giovannucci E; Harlan DM; Archer MC; Bergenstal RM; Gapstur SM; Habel LA; Pollak M; Regensteiner JG; Yee D
    CA Cancer J Clin; 2010; 60(4):207-21. PubMed ID: 20554718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diet and tumor LKB1 expression interact to determine sensitivity to anti-neoplastic effects of metformin in vivo.
    Algire C; Amrein L; Bazile M; David S; Zakikhani M; Pollak M
    Oncogene; 2011 Mar; 30(10):1174-82. PubMed ID: 21102522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes and cancer.
    Chowdhury TA
    QJM; 2010 Dec; 103(12):905-15. PubMed ID: 20739356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth.
    Algire C; Zakikhani M; Blouin MJ; Shuai JH; Pollak M
    Endocr Relat Cancer; 2008 Sep; 15(3):833-9. PubMed ID: 18469156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new link between diabetes and cancer: enhanced WNT/β-catenin signaling by high glucose.
    García-Jiménez C; García-Martínez JM; Chocarro-Calvo A; De la Vieja A
    J Mol Endocrinol; 2014 Feb; 52(1):R51-66. PubMed ID: 24049067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin: a new treatment option for non-insulin-dependent diabetes mellitus.
    Goo AK; Carson DS; Bjelajac A
    J Fam Pract; 1996 Jun; 42(6):612-8. PubMed ID: 8656173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane physiology as a basis for the cellular effects of metformin in insulin resistance and diabetes.
    Wiernsperger NF
    Diabetes Metab; 1999 Jun; 25(2):110-27. PubMed ID: 10443322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes.
    Gupta A; Bisht B; Dey CS
    Neuropharmacology; 2011 May; 60(6):910-20. PubMed ID: 21277873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin as an antitumor agent in cancer prevention and treatment.
    Li D
    J Diabetes; 2011 Dec; 3(4):320-7. PubMed ID: 21631893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells.
    Zakikhani M; Dowling R; Fantus IG; Sonenberg N; Pollak M
    Cancer Res; 2006 Nov; 66(21):10269-73. PubMed ID: 17062558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects.
    Pierotti MA; Berrino F; Gariboldi M; Melani C; Mogavero A; Negri T; Pasanisi P; Pilotti S
    Oncogene; 2013 Mar; 32(12):1475-87. PubMed ID: 22665053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity and insulin resistance in breast cancer--chemoprevention strategies with a focus on metformin.
    Goodwin PJ; Stambolic V
    Breast; 2011 Oct; 20 Suppl 3():S31-5. PubMed ID: 22015290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin and exercise reduce muscle FAT/CD36 and lipid accumulation and blunt the progression of high-fat diet-induced hyperglycemia.
    Smith AC; Mullen KL; Junkin KA; Nickerson J; Chabowski A; Bonen A; Dyck DJ
    Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E172-81. PubMed ID: 17374701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosiglitazone reduces the accelerated neointima formation after arterial injury in a mouse injury model of type 2 diabetes.
    Phillips JW; Barringhaus KG; Sanders JM; Yang Z; Chen M; Hesselbacher S; Czarnik AC; Ley K; Nadler J; Sarembock IJ
    Circulation; 2003 Oct; 108(16):1994-9. PubMed ID: 14517165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin amplifies chemotherapy-induced AMPK activation and antitumoral growth.
    Rocha GZ; Dias MM; Ropelle ER; Osório-Costa F; Rossato FA; Vercesi AE; Saad MJ; Carvalheira JB
    Clin Cancer Res; 2011 Jun; 17(12):3993-4005. PubMed ID: 21543517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.